|
Volumn 324, Issue 7336, 2002, Pages 520-523
|
Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: Double blind randomised controlled clinical trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLERGEN;
PLACEBO;
ADULT;
ALTERNATIVE MEDICINE;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DERMATOPHAGOIDES PTERONYSSINUS;
DOUBLE BLIND PROCEDURE;
FEMALE;
FORCED EXPIRATORY VOLUME;
HOMEOPATHY;
HOUSE DUST ALLERGY;
HUMAN;
IMMUNOTHERAPY;
MAJOR CLINICAL STUDY;
MALE;
MOOD;
MULTICENTER STUDY;
PEAK EXPIRATORY FLOW;
PRICK TEST;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
AFFECT;
ANIMALS;
ASTHMA;
DOUBLE-BLIND METHOD;
DUST;
FEMALE;
FORCED EXPIRATORY VOLUME;
HOMEOPATHY;
HUMANS;
HYPERSENSITIVITY, IMMEDIATE;
MALE;
MIDDLE AGED;
MITES;
QUALITY OF LIFE;
SKIN TESTS;
TIME FACTORS;
TREATMENT FAILURE;
|
EID: 0037006618
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (111)
|
References (21)
|